Skip to main content
Top
Published in: Clinical Rheumatology 1/2008

01-01-2008 | Original Article

Thrombophlebitis migrans as a footprint of Buerger’s disease: a prospective–descriptive study in north-east of Iran

Authors: Bahare Fazeli, Hadi Modaghegh, Hasan Ravrai, Gholamhossein Kazemzadeh

Published in: Clinical Rheumatology | Issue 1/2008

Login to get access

Abstract

The pathogenesis of thrombophlebitis migrans is as unknown as the etiology of Buerger’s disease (BD). In the past, thrombophlebitis migrans was a major criterion used in the diagnosis of BD, whereas today it is not as important as before and it is often forgotten to be asked about from patients with BD. In this project, during a 22-month prospective study on 86 patients suffering from BD, 65.4% had the history or sign of thrombophlebitis migrans, which in 25.6% of them, it was the first presentation of the disease and in 4.7% of them, it was the main cause of complaint. Thrombophlebitis migrans had initially occurred 9 years before the patient showed any sign of the disease (with the time range of a maximum of 22 years and a minimum of 4 months). In 45% of patients who had recommenced cigarette smoking, thrombophlebitis migrans occurred about 1–4 months before the new onset of their acute ischemic signs. Superficial thrombophlebitis migrans can be considered as a warning sign for BD onset in Asian young male smokers. With regard to the variety in the clinical feature and localization of appearance of thrombophlebitis migrans in the studied patients and its unknown pathogenesis, there should be more studies and researches toward understanding the nature of BD and thrombophlebitis migrans as its footprint.
Footnotes
1
Mashhad Vascular Surgery Research Center (MvasRc) is located in the Imam Reza Hospital in Mashhad, the second biggest city after Tehran, in the north-east of Iran and in Khorasan Province. Khorasan is the largest province in Iran with 302,966 km2 and, according to the 2001 census, has a population of over 6 million. Mashhad is the center of this province, so the studied patients were from the urban and rural areas of Khorasan Province who were referred to MVasRc. In addition to the patients from this province, there were some patients from the neighboring province (Golestan Province) at the Caspian Sea during this study.
 
2
Indices for poverty: (1) basic requirements for living such as food and clothing; (2) hygiene and tidiness; (3) level of education; (4) occupation; and (5) adequate work (duration, quality, and income).
 
Literature
2.
go back to reference Sneller MC, Langford CA, Fauci AS (2005) The vasculitis syndromes. In: Braunwal E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL (eds) Harrison’s principles of internal medicine, 16th edn. McGraw-Hill, New York, pp 1956–1967 Sneller MC, Langford CA, Fauci AS (2005) The vasculitis syndromes. In: Braunwal E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL (eds) Harrison’s principles of internal medicine, 16th edn. McGraw-Hill, New York, pp 1956–1967
3.
go back to reference Stvrtinova V, Ambrozy E, Stvrtina S, Lesny P (1999) 90 years of Buerger’s disease—what has changed? Bratisl Lek Listy 100(3):123–128PubMed Stvrtinova V, Ambrozy E, Stvrtina S, Lesny P (1999) 90 years of Buerger’s disease—what has changed? Bratisl Lek Listy 100(3):123–128PubMed
4.
go back to reference Olin JW, Young JR, Graor RA, Ruschhaupt WF, Bartholomew JR (1990) The changing clinical spectrum of thromboangiitis obliterans (Buerger’s disease). Circulation 82(5 Suppl):IV3–IV8PubMed Olin JW, Young JR, Graor RA, Ruschhaupt WF, Bartholomew JR (1990) The changing clinical spectrum of thromboangiitis obliterans (Buerger’s disease). Circulation 82(5 Suppl):IV3–IV8PubMed
5.
go back to reference Fernandez-Miranda C, Rubio R, Vicario JL, Arnaiz A et al (1993) Thromboangiitis obliterans (Buerger’s disease). Study of 41 cases. Med Clin (Barc) 101(9):321–326 Fernandez-Miranda C, Rubio R, Vicario JL, Arnaiz A et al (1993) Thromboangiitis obliterans (Buerger’s disease). Study of 41 cases. Med Clin (Barc) 101(9):321–326
6.
go back to reference Olin JW (2000) Thromboangiitis obliterans (Buerger’s disease). In: Rutherford R (ed) Vascular surgery, 5th edn. Saunders, Philadelphia, pp 350–362 Olin JW (2000) Thromboangiitis obliterans (Buerger’s disease). In: Rutherford R (ed) Vascular surgery, 5th edn. Saunders, Philadelphia, pp 350–362
7.
go back to reference Allen E, Barker N, Hines E (1972) Peripheral vascular diseases, 4th edn. Saunders, Philadelphia, pp 326–349 Allen E, Barker N, Hines E (1972) Peripheral vascular diseases, 4th edn. Saunders, Philadelphia, pp 326–349
9.
go back to reference Shionoya S (1998) Diagnostic criteria of Buerger’s disease. Int J Cardiol 66(Suppl 1):S243–S245PubMedCrossRef Shionoya S (1998) Diagnostic criteria of Buerger’s disease. Int J Cardiol 66(Suppl 1):S243–S245PubMedCrossRef
Metadata
Title
Thrombophlebitis migrans as a footprint of Buerger’s disease: a prospective–descriptive study in north-east of Iran
Authors
Bahare Fazeli
Hadi Modaghegh
Hasan Ravrai
Gholamhossein Kazemzadeh
Publication date
01-01-2008
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 1/2008
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-007-0652-8

Other articles of this Issue 1/2008

Clinical Rheumatology 1/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.